Dural sinus thrombosis complicated with heparin induced thrombocytopenia and thrombosis (HITT)

Interventional Neuroradiology

Volumn 8, Issue 1, 2002, Pages 77-80

  Lee, S K ^a   Willinsky, R ^a   TerBrugge, K ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Dural sinus trombosis; Thrombocytopenia; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LIPERIDIN;

ADULT; APHASIA; ARTICLE; ARTIFICIAL EMBOLISM; ATHEROSCLEROTIC PLAQUE; BLOOD CLOT LYSIS; CAROTID ARTERY THROMBOSIS; CASE REPORT; CEREBRAL SINUS THROMBOSIS; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; FEMALE; HEADACHE; HEMIPARESIS; HEMIPLEGIA; HIGH RISK PATIENT; HUMAN; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; NEURORADIOLOGY; PARESTHESIA; PATHOPHYSIOLOGY; POLYCYTHEMIA; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0036267536     PISSN: 11239344     EISSN: None     Source Type: Journal    
DOI: 10.1177/159101990200800114     Document Type: Article

References (12)

1. Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy
2. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin
3. The incidence of heparin-induced antibodies in patients undergoing vascular surgery: A prospective study
4. Heparin-induced thrombocytopenia and thrombosis: A prospective analysis of the incidence in patients with heart and cerebrovascular diseases
5. Endovascular repair of an extracranial internal carotid artery aneurysm complicated by heparin-induced thrombocytopenia and thrombosis
6. Treatment of May-Thurner syndrome with catheter-directed thrombolysis and stent placement, complicated by heparin-induced thrombocytopenia
7. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells
8. Heparin-associated thrombocytopenia and thrombosis: Implications for perioperative management
9. Heparin-associated thrombocytopenia and thrombosis: A serious clinical problem and potential solution
10. Neurologic complications in immune-mediated heparin-induced thrombocytopenia
11. A 14-year study of heparin-induced thrombocytopenia
12. Deep vein thrombosis, pulmonary embolism, and the white clot syndrome